(58 days)
No
The summary describes a standard automated blood gas analyzer and does not mention any AI or ML capabilities.
No.
The device is an analyzer that measures various parameters in blood for diagnostic purposes, not for treating or providing therapy.
Yes
The device measures various parameters (pH, blood gases, electrolytes, glucose, lactate, and oximetry) in whole blood, and these measurements are explicitly stated to be "used in the diagnosis and treatment" of numerous diseases and conditions, which is the definition of a diagnostic device.
No
The device description explicitly states it is a "portable, automated system intended for in vitro testing of samples of whole blood" and measures various parameters using physical samples, indicating it includes hardware components for analysis.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the analyzer "measures pH, blood gases, electrolytes, glucose, lactate, and oximetry in heparinised whole blood." These are measurements performed on biological samples (whole blood) outside of the body.
- Device Description: The "Device Description" further clarifies that the system is "intended for in vitro testing of samples of whole blood". "In vitro" means "in glass" or "outside of the living organism," which is the definition of an in vitro diagnostic.
- Parameters Measured: The parameters measured (pH, blood gases, electrolytes, glucose, lactate, and oximetry) are all common diagnostic tests performed on blood samples to aid in the diagnosis and treatment of various medical conditions.
- Care Setting: While it can be used near the patient or at the point-of-care, it is also intended for use in a "laboratory environment," which is a typical setting for IVD testing.
The information provided clearly indicates that the ABL90 FLEX analyzer is designed to perform diagnostic tests on biological samples outside of the body, which is the defining characteristic of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The ABL90 FLEX analyzer is a portable, automated analyzer that measures pH, blood gases, electrolytes, glucose, lactate, and oximetry in heparinised whole blood. The ABL90 FLEX analyzer is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting. These tests are only performed under a physician's order.
pH, pO2 and pCO2: pH, pCO2 and pO2 measurements are used in the diagnosis and treatment of life-threatening acid-base disturbances.
Potassium (cKT): potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels.
Sodium (cNa*): sodium measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipids, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic secretion, or other diseases involving electrolyte imbalance.
Calcium (cCart): calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany.
Chloride (cCI¯): chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such a cystic fibrosis and diabetic acidosis.
Glucose (cGlu): glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
Lactate (cLac): The lactate measurements measure the concentration of lactate in plasma. Lactate measurements are used to evaluate the acid-base status and are used in the diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood.)
Total Hemoglobin (ctHb): total hemoglobin measurements are used to measure the hemoglobin content of whole blood for the detection of anemia.
sO2: oxygen saturation, more specifically the ratio between the concentration of oxyhemoglobin and oxyhemoglobin plus reduced hemoqlobin.
FO2Hb: oxyhemoglobin as a fraction of total hemoglobin.
FCOHb: carboxyhemoglobin measurements are used to determine the carboxyhemoglobin content of human blood as an aid in the diagnosis of carbon monoxide poisoning.
FMetHb: methemoglobin as a fraction of total hemoglobin.
FHHb: reduced hemoglobin as a fraction of total hemoglobin.
Fraction of Fetal Hemoglobin (FHbF): FHbF indicates the amount of fetal hemoglobin. FHbF is seldom used clinically.
Product codes (comma separated list FDA assigned to the subject device)
CHL, CEM, JFP, CGZ, CGA, KHP, GKR, GHS, KQI, JJY, JIX
Device Description
The ABL90 FLEX is a portable, automated system intended for in vitro testing of samples of whole blood for the parameters pH, pO2 , pCO2, potassium, sodium, chloride, glucose, lactate, and co-oximetry parameters (total hemoglobin, oxygen saturation, and the hemoglobin fractions FO2Hb, FCOHb, F MetHb, FHHb and FHbF).
The implementation of the WiFi option allows wireless functionality for establishing network connectivity; all of which is supported by wired LAN connection in the existing application.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
No performance characteristics are affected by the change. The performance data submitted in the original submission (K092686) still apply.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1120 Blood gases (P
CO2 , PO2 ) and blood pH test system.(a)
Identification. A blood gases (PCO2 , PO2 ) and blood pH test system is a device intended to measure certain gases in blood, serum, plasma or pH of blood, serum, and plasma. Measurements of blood gases (PCO2 , PO2 ) and blood pH are used in the diagnosis and treatment of life-threatening acid-base disturbances.(b)
Classification. Class II.
0
Special 510(k): Device Modification to ABL90 Flex - WiFi
RADIOMETER ®
Section 5. 510(k) Summary
OCT 2 6 2012
1. Administrative
| Device Information | |
|---|---|
| Device Name: | ABL90 Flex |
| Common Name: | Blood gases and blood pH test system |
| Product Code: | CHL (JGS, CEM, JFP, CGZ, CGA, KHP, GKR, GHS, KQI, JJY, JIX) |
| Registration Number: | 21 CFR 862.1120 |
| Classification: | Class II |
| Classification Panel: | Clinical Chemistry |
| Submitter |
| Company Name: | Radiometer Medical ApS |
|---|---|
| ER Number: | 3002807968 |
| Address: | Aakandevej 21 |
| 2700 Broenshoej | |
| Denkmark | |
| Phone: | +45 3827 3827 |
| Fax: | +45 3827 2727 |
2. Description of Device Modification
The ABL90 FLEX is a portable, automated system intended for in vitro testing of samples of whole blood for the parameters pH, pO2 , pCO2, potassium, sodium, chloride, glucose, lactate, and co-oximetry parameters (total hemoglobin, oxygen saturation, and the hemoglobin fractions FO2Hb, FCOHb, F MetHb, FHHb and FHbF).
The implementation of the WiFi option allows wireless functionality for establishing network connectivity; all of which is supported by wired LAN connection in the existing application.
3. Intended Use
The ABL90 FLEX is a portable, automated analyzer that measures pH, blood gases, electrolytes, glucose, lactate and oximetry in heparinised whole blood. The ABL90 FLEX is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting.
4. Substantial Equivalence
The ABL90 FLEX with the implementation of the WiFi option is substantially equivalent in Intended Use, fundamental scientific technology, features, and characteristics to the predicate:
510(k) Number/Device Manufacturer:
K092686 ABL90 Flex, Radiometer Medical ApS (subsequent submissions: K111897, K120197)
1
Special 510(k): Device Modification to ABL90 Flex - WiFi
RADIOMETER IR
| Predicate: ABL90 Flex (K092682) | |
|---|---|
| Similarities | Differences |
| Intended Use | |
| The ABL90 FLEX is a portable, automated | |
| analyzer that measures pH, blood gases, | |
| electrolytes, glucose, lactate and oximetry in | |
| heparinised whole blood. The ABL90 FLEX is | |
| intended for use by trained technologists, | |
| nurses, physicians and therapists. It is | |
| intended for use in a laboratory environment, | |
| near patient or point-of-care setting. | Wireless LAN network connectivity utilizing |
| standard technology and protocols provided | |
| and supported by the operating system | |
| (Windows XP Embedded). Currently this is | |
| provided by establishing cabled LAN | |
| connections. | |
| Blood Gas Measurement | |
| pH, pO₂, pCO₂ by potentiometry | |
| Electrolyte Measurement | |
| cK⁺, cNa⁺, cCa²⁺, cCl⁻ by potentiometry | |
| Metabolite Measurement | |
| cGlu, cLac by amperometry | |
| Oximetry Measurement | |
| ctHb, sO₂ FO₂Hb, FHHb, FCOHb, FMetHb, | |
| FHbF | |
| Hemoglobin Measurement | |
| Spectrophotometry | |
| Identical Performance Characteristics | |
| Two-Point liquid calibration | |
| Menu driven touch screen | |
| Software operating system | |
| Microsoft XPE | |
| Sample Introduction | |
| Aspiration | |
| Dimensions (length x width x depth) | |
| External Power Source | |
| 230/120 V mains |
5. Performance Data
No performance characteristics are affected by the change. The performance data submitted in the original submission (K092686) still apply.
6. Conclusion
The ABL90 FLEX with the modification described above is substantially equivalent in Intended Use, fundamental scientific technology, and characteristics to the predicate ABL90 Flex. For the implementation of the change design control principles (risk management, verification, validation) have been applied which indicated that the change is of no impact to the performance of the device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its body or wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol. The text is in all capital letters and is evenly spaced around the circle.
10903 New Hampshire Avenue Silver Spring, MD 20993
Radiometer Medical ApS c/o Martin Gabler Aakandevej 21 Denmark DK-2700
OCT 26 2012
Re: K122642
Trade Name: ABL90 Flex Analyzer Regulation Number: 21 CFR §862.1120 Regulation Name: Blood gases and blood pH test system Regulatory Class: Class II Product Codes: CHL, CEM, CGA, CGZ, GHS, GKR, JFP, JGS, JIX, KHP, KQI, JJY Dated: October 1, 2012 Received: October 3, 2012
Dear Mr. Gabler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
3
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please rr you dealle specific at hitro Diagnostic Devices and Radiological Health at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH'S (21 CFA Part 001197) 1 or Galleric's (OSB's) Division of Postmarket Surveillance at (301) Office of Dal valiano and Drolling of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical
OFF it For 805), preace aroblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance ...
You may obtain other general information on your responsibilities under the Act from the r ou may other of Small Manufacturers, International and Consumer Assistance at its toll-free number (800 638-2041 or (301) 796-5680 or at its Internet address http://www.fda/gov/MedicalDevices/ResourcesforYou/Industry/default.htm
Sincerely yours,
Courtney H. Lias, Ph.D Director Division of Chemistry and Toxicology Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K122642
Device Name: ABL90 Flex Analyzer
Indications For Use:
The ABL90 FLEX analyzer is a portable, automated analyzer that measures pH, blood gases, electrolytes, glucose, lactate, and oximetry in heparinised whole blood. The ABL90 FLEX analyzer is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting. These tests are only performed under a physician's order.
pH, pO2 and pCO2: pH, pCO2 and pO2 measurements are used in the diagnosis and treatment of life-threatening acid-base disturbances.
Potassium (cKT): potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels.
Sodium (cNa*): sodium measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic secretion, or other diseases involving electrolyte imbalance.
Calcium (cCart): calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany.
Chloride (cCI¯): chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such a cystic fibrosis and diabetic acidosis.
Prescription Use X (21 CFR Part 801 Subpart D) And/Or
Over the Counter Use (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIR)
Bustle Ch
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) &(2.2642
5
Indications for Use
510(k) Number (if known): K122642
Device Name: ABL90 Flex Analyzer
Indications For Use:
Glucose (cGlu): glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
Lactate (cLac): The lactate measurements measure the concentration of lactate in plasma. Lactate measurements are used to evaluate the acid-base status and are used in the diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood.)
Total Hemoglobin (ctHb): total hemoglobin measurements are used to measure the hemoglobin content of whole blood for the detection of anemia.
sO2: oxygen saturation, more specifically the ratio between the concentration of oxyhemoglobin and oxyhemoglobin plus reduced hemoqlobin.
FO2Hb: oxyhemoglobin as a fraction of total hemoglobin.
FCOHb: carboxyhemoglobin measurements are used to determine the carboxyhemoglobin content of human blood as an aid in the diagnosis of carbon monoxide poisoning.
FMetHb: methemoglobin as a fraction of total hemoglobin.
FHHb: reduced hemoglobin as a fraction of total hemoglobin.
Fraction of Fetal Hemoglobin (FHbF): FHbF indicates the amount of fetal hemoglobin. FHbF is seldom used clinically.
And/Or Over the Counter Use Prescription Use X (21 CFR Part 801 Subpart D) (21 CFR Part 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIR)
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
K122642 510(k)
2